Mojo Vision’s really smart vision correcting/AR contact lenses

January 31, 2020 | by

Didn’t Novartis and Google give up on ‘smart lenses’ in 2014 or so? Instead of a drug delivery system, Mojo Vision has a more realistic view of contact lenses–vision correction and compensations for vision impairments–plus some augmented reality add-ons that could be useful not only for vision enhancement but also in hazardous situations and for service professionals.  The potential for these lenses is great, not only in the corrective ability to increase contrast or enhance color, but also in their technology which can display simple information on the lens. The display focuses light on the fovea, the central portion of the cornea which has most of the eye’s photoreceptors. The display is powered by a thin-film battery and in a future iteration will connect to your smartphone.

Mark Sullivan from Fast Company has been covering Mojo for a while and as promised at the top of the article, it’s a long read about the lenses and the developers, who for a refreshing change are not 30. It’s still unnerving to read about contact lenses with batteries and images projected on your retina, but if this ‘moonshot’ works, it could be a breakthrough in vision correction far beyond conventional lenses.

Contact lenses as a drug delivery system take home MIT Sloan Healthcare prize

March 21, 2018 | by

This Editor has been covering contact lenses in health tech since at least 2013–contact lenses that detect glucose for diabetics (Google/Novartis/Alcon), eye pressure (Sensimed), and even detect multiple diseases (Oregon State University). None to date have made it into commercial release.

Here’s another try, this time from this year’s winner of the MIT Sloan Healthcare Innovation Prize competition. Theraoptix won the $25,000 grand prize, sponsored by Optum. The lenses are designed to deliver eye medication on a time release basis using a thin polymer film formed into a tiny circular strip sandwiched into the lens material. They can be worn for up to two weeks to slowly but constantly deliver drugs in the treatment of diseases like glaucoma or after surgery. It can also deliver drugs effectively for back of the eye treatment of macular degeneration, diabetic retinopathy, retinal vein occlusion, and similar diseases that today require in-office injections.

Theraoptix was developed by Lokendra Bengani Ph.D. of the Schepens Eye Research Institute of the Massachusetts Eye and Ear Infirmary. It was based on core technology by ophthalmologist Joseph B. Ciolino MD, who is Dr. Bengani’s mentor. We wrote about Dr. Ciolino’s research previously [TTA 7 Sept 16] including a look back at contact lens research. There were seven other finalists, of which the most interesting to this Editor was Kinematics shoe insole sensors for gait detection analysis (and fall prevention).  MIT News. 

Google Contact Lens for diabetics in development

January 17, 2014 | by | 1 Comment

Breaking news

[grow_thumb image=”https://telecareaware.com/wp-content/uploads/2013/02/gimlet-eye.jpg” thumb_width=”130″ /][grow_thumb image=”https://telecareaware.com/wp-content/uploads/2014/01/Hand-holding-zoomed-in.jpg” thumb_width=”150″ /]It’s unusual that a smart contact lens that measures blood glucose makes lead worldwide news while it is still in clinical studies, but when it is from Google, The Gimlet Eye wants to be the first to try it.

Google’s blog and a single interview they granted to the Associated Press have confirmed the earlier rumor on a blood glucose-measuring contact that first appeared last Friday [TTA 10 January; item from FierceMedicalDevices in the 4th paragraph, Google’s meeting with FDA on a powered contact lens]. The AP article also confirmed its genesis in University of Washington/NSF research. The Google lens under development might have tiny LED lights that visually advise the wearer on their glucose levels, as well as transmit the information via a wireless chip. Last week’s speculation was on a Google Glass-like display à la iOptik.

Research specifically directed towards continual monitoring of the blood glucose in tears has been ongoing and other companies have developed powered lenses. A key question is the equivalence and accuracy of monitoring tears versus blood. (more…)

The CES of Health (Friday)

January 10, 2014 | by

Rounding up the 10 Ring Vegas Circus-Circus, it’s time for ‘best and worst lists’: hopping with the Kiwi tracker, no one’s kind to Mother, in the kitchen with 3D printers and what may be up with Google, FDA and contact lenses.

[grow_thumb image=”https://telecareaware.com/wp-content/uploads/2014/01/02-itoi-620×400.jpg” thumb_width=”150″ /]ZDNet rounds up its Friday coverage with a Best of CES selection. It’s always interesting to get the broader non-healthcare techie view of ‘what’s hot’–they spotted fitness bands early when even diehard QSers were skeptical– and to then see if their picks make it into the broader market. Their health tech picks are the Mimo Baby onesie + detachable turtle monitor from Rest Devices (sure to be a hit at your next baby shower; TTA 10 Sept], movement profiler Notch(see Thursday; it also made The Guardian’s roundup), MakerBot’s home 3D Replicator Mini (Wednesday) and the Epson Moverio BT200 digital content projection smart glasses  (in-market March, @ $699.99 a bargain for what use?). Au contraire, see 11 born-to-fail worst gadgets which includes being mean to Sen.se’s Mother and, in worst design, an iPad video ‘periscope’ from iTOi which looked like it was stolen off the set of the 1956 space opera Forbidden Planet. For today’s market, it definitely could have used a steampunk vibe to carry off its ‘Blue Blazes’ design.

Yet one of their writers gives Mother, a/k/a the “M2M Mollycoddle”, “part-Russian doll and part-Doctor Who monster”, a more thoughtful once-over. (more…)